Picture of Elicio Therapeutics logo

ELTX — Elicio Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareMicro CapSucker Stock

Brief: Angion Says Receives Nasdaq Notice Regarding Minimum Bid Price Requirements

Dec 21 (Reuters) - Angion Biomedica Corp  ANGN.O :
    * ANGION RECEIVES NASDAQ NOTICE REGARDING MINIMUM BID PRICE
REQUIREMENTS
    * ANGION BIOMEDICA- NOTIFIED BY NASDAQ LISTING
QUALIFICATIONS
STAFF THAT SINCE LAST 30 DAYS BID PRICE OF CO'S COMMON STOCK HAD
CLOSED BELOW $1.00/SHARE

Source text for Eikon:  ID:nGNX8MN6vz 
Further company coverage:  ANGN.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Elicio Therapeutics

See all news